Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

16.80
Delayed Data
As of Sep 20
 +0.15 / +0.90%
Today’s Change
10.75
Today|||52-Week Range
19.90
+11.63%
Year-to-Date
Biosimilar 2017 Progress Report: Stocks in Focus
Sep 14 / Zacks.com - Paid Partner Content
Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?
Sep 11 / Zacks.com - Paid Partner Content